New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
18:04 EDTRDUSRadius Health withdraws registration statement on form S-1
In a regulatory filing Radius said: Radius Healtth hereby applies for withdrawal of the company’s registration statement on Form S-1 filed with the Securities and Exchange Commission on February 6, 2012 and amended on September 28, October 19 and November 7. Pursuant to Rule 477 under the Securities Act of 1933, as amended the company is withdrawing the Registration Statement, which has not been declared effective, because the proposed public offering under the Registration Statement was abandoned due to general market conditions. Since the Registration Statement was not declared effective by the Commission, no shares of common stock as described in the Registration Statement were sold. In addition, the Company hereby applies for withdrawal of the Company’s Registration Statement on Form 8-A, filed with the Commission on November 5.
News For RDUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
17:31 EDTRDUSRadius Health hires Dr. Lorraine Fitzpatrick as Chief Medical Officer
Radius Health (RDUS) announced that it has hired Dr. Lorraine A. Fitzpatrick as Chief Medical Officer of the Company. Dr. Fitzpatrick was previously Medicine Development Leader of an international clinical development team for Denosumab at GlaxoSmithKline (GSK), responsible for clinical development, regulatory, manufacturing, commercial, operations, epidemiology, and global health outcomes. Previously, Dr. Fitzpatrick led the clinical development of novel agents to treat musculoskeletal diseases and women's health at GlaxoSmithKline. Before joining GlaxoSmithKline, Dr. Fitzpatrick was Executive Director at Amgen, Inc. where she worked in the fields of osteoporosis and oncology.
July 23, 2015
06:04 EDTRDUSRadius Health 4.1M share Secondary priced at $74.00
Subscribe for More Information
July 22, 2015
09:07 EDTRDUSOn The Fly: Pre-market Movers
Subscribe for More Information
07:59 EDTRDUSRadius Health breakthrough therapy request for abaloparatide-SC denied by FDA
Subscribe for More Information
July 21, 2015
19:00 EDTRDUSOn The Fly: After Hours Movers
Subscribe for More Information
16:04 EDTRDUSRadius Health files to sell $250M in common stock
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use